News
Media coverage of HCCI’s original research
For general media inquiries or to propose collaborative projects, please contact us
USA Today: Walmart launching its own low-cost insulin to 'revolutionize' affordability for diabetics
HCCI's research on insulin prices was featured in USA Today.
From the article: "The lower-cost insulin is being released by Walmart in response to surging costs for the treatment used for patients with diabetes. According to the Health Care Cost Institute, a non-profit organization which sheds light on health care spending, the average price for an insulin prescription nearly doubled from 2012 ($344) to 2016 ($666)."
Walmart launching its own low-cost insulin for diabetes patients
Walmart will launch its own brand of insulin, which the retailing giant says will "revolutionize the access and affordability" of diabetes treatments.
By accepting you will be accessing a service provided by a third-party external to https://healthcostinstitute.org/
©
2022
Health Care Cost Institute Inc. Unless explicitly noted, the content on this website is licensed under a Creative Commons Attribution Non-Commercial No Derivatives 4.0 License